TW202408557A - Composition for boosting immunity and use thereof - Google Patents

Composition for boosting immunity and use thereof Download PDF

Info

Publication number
TW202408557A
TW202408557A TW111130782A TW111130782A TW202408557A TW 202408557 A TW202408557 A TW 202408557A TW 111130782 A TW111130782 A TW 111130782A TW 111130782 A TW111130782 A TW 111130782A TW 202408557 A TW202408557 A TW 202408557A
Authority
TW
Taiwan
Prior art keywords
shrimp
composition
pleurotus eryngii
strain
lactobacillus plantarum
Prior art date
Application number
TW111130782A
Other languages
Chinese (zh)
Other versions
TWI820864B (en
Inventor
劉俊宏
胡紹揚
邱謝聰
Original Assignee
國立屏東科技大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國立屏東科技大學 filed Critical 國立屏東科技大學
Priority to TW111130782A priority Critical patent/TWI820864B/en
Application granted granted Critical
Publication of TWI820864B publication Critical patent/TWI820864B/en
Publication of TW202408557A publication Critical patent/TW202408557A/en

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A composition for boosting immunity includes an extract of Pleurotus eryngiiobtained by extracting a sample of Pleurotus eryngiiby water in a boiled condition, and a strain of Lactobacillus plantarum7-40 which is deposited at Bioresource Collection and Research Center of Taiwan with a deposit number BCRC 911128. A use of the composition for manufacturing a medicament for boosting immunity of shrimp is also disclosed.

Description

用以提升免疫能力的組合物及其用途Compositions for improving immunity and uses thereof

本發明係關於一種組合物,尤其是一種用以提升免疫能力的組合物。本發明另關於該組合物用以製備提升蝦體免疫能力之藥物的用途。The present invention relates to a composition, especially a composition for improving immunity. The present invention also relates to the use of the composition for preparing a medicine for improving the immunity of shrimps.

近年來,台灣蝦類養殖蓬勃發展,蝦體不僅可以作為食物來源,亦可以外銷為國家帶來豐富的經濟效益。由於蝦體養殖快速發展,而限於土地價格高,養殖業者須採用高密度養殖,以降低成本。In recent years, Taiwan's shrimp farming has been booming. Shrimp bodies can not only be used as a food source, but can also be exported, bringing rich economic benefits to the country. Due to the rapid development of shrimp farming and high land prices, farmers must adopt high-density farming to reduce costs.

高密度的養殖方式會造成養殖環境惡化,使蝦體之間容易相互傳染疾病,因而會使蝦體的死亡率上升;為了降低死亡率,養殖業者常會於飼料中添加抗生素,然而抗生素的濫用,不僅是導致食用者攝取蝦體而發生過敏的原因,亦可能會誘發病原菌產生抗藥性,因此仍需進一步的改善。High-density farming methods can cause the farming environment to deteriorate, making it easier for shrimps to spread diseases to each other, thus increasing the shrimp mortality rate. In order to reduce the mortality rate, farmers often add antibiotics to the feed. However, the abuse of antibiotics not only causes consumers to develop allergies after ingesting shrimps, but may also induce pathogens to develop drug resistance. Therefore, further improvement is still needed.

為解決上述問題,本發明的目的是提供一種用以提升免疫能力的組合物,係可以提升蝦類之免疫能力者。In order to solve the above problems, the object of the present invention is to provide a composition for improving immunity, which can improve the immunity of shrimps.

本發明的次一目的是提供前述組合物的用途,係可以供投予一蝦體,以免除抗生素的使用者。Another object of the present invention is to provide a use of the aforementioned composition, which can be administered to a shrimp to avoid the need for antibiotic users.

本發明的用以提升免疫能力的組合物,包含:一杏鮑菇萃取物,該杏鮑菇萃取物係以水於沸騰的狀態下萃取一杏鮑菇樣品獲得;及一植物乳桿菌7-40菌株,該植物乳桿菌7-40菌株係寄存於中華民國食品工業發展研究所,該植物乳桿菌7-40菌株的寄存編號為BCRC 911128。舉例而言,每公斤的組合物可以包含5~6公克的杏鮑菇萃取物及10 8CFU的植物乳桿菌7-40菌株。 The composition for enhancing immunity of the present invention comprises: an extract of King Pleurotus eryngii, which is obtained by extracting a King Pleurotus eryngii sample with water under boiling state; and a strain of Lactobacillus plantarum 7-40, which is deposited in the Food Industry Development Research Institute of the Republic of China, and the deposit number of the strain of Lactobacillus plantarum 7-40 is BCRC 911128. For example, each kilogram of the composition may contain 5-6 grams of King Pleurotus eryngii extract and 10 8 CFU of the strain of Lactobacillus plantarum 7-40.

據此,本發明的組合物包含該杏鮑菇萃取物及該植物乳桿菌7-40菌株,因此可以藉由二者的加乘作用,達成有效提升蝦類的免疫能力之功效。Accordingly, the composition of the present invention includes the Pleurotus eryngii extract and the Lactobacillus plantarum 7-40 strain. Therefore, the effect of effectively improving the immunity of shrimps can be achieved through the additive effect of the two.

本發明的用以提升免疫能力的組合物,其中,該杏鮑菇樣品係可以為一杏鮑菇菌托樣品。如此,使原本被認定為農業廢棄物的菌托具有新的經濟價值,達成為菌托創造新的經濟出路之功效。In the composition for enhancing immunity of the present invention, the Pleurotus ostreatus sample can be a Pleurotus ostreatus cultivar sample. In this way, the cultivar cultivar, which was originally considered as agricultural waste, has a new economic value, achieving the effect of creating a new economic outlet for the cultivar cultivar.

本發明的組合物的用途,係用以製備提升蝦體免疫能力之藥物,該組合物係投予一蝦體,以增強該蝦體之免疫能力。The use of the composition of the present invention is to prepare a drug for enhancing the immune ability of shrimp. The composition is administered to a shrimp to enhance the immune ability of the shrimp.

據此,藉由該杏鮑菇萃取物及該植物乳桿菌7-40菌株的共同使用,可以促進蝦類的細胞免疫反應(例如提升血球細胞溶菌酶活性),因此當受到溶藻弧菌等病原菌的感染時,可以降低蝦類遭受病原菌攻擊所造成之死亡,是以可以降低養殖業者於養殖過程中的抗生素使用量,為本發明之功效。Accordingly, by using the King Oyster Mushroom extract and the Lactobacillus plantarum 7-40 strain together, the cellular immune response of shrimps can be promoted (for example, the activity of lysozyme in blood cells can be enhanced). Therefore, when the shrimps are infected by pathogens such as Vibrio alginolyticus, the death rate caused by the attack of pathogens can be reduced. Therefore, the amount of antibiotics used by farmers in the breeding process can be reduced, which is the effect of the present invention.

本發明的組合物的用途,其中,該組合物係能夠以經口餵食的方式投予該蝦體,較佳可以與一飼料混合形成一混合物,並與該飼料共同投予該蝦體;如此該組合物可以直接投於養殖水中,使該蝦體可以自由攝食,提升投予該組合物的便利性。The use of the composition of the present invention, wherein the composition can be administered to the shrimp body in an oral feeding manner, preferably it can be mixed with a feed to form a mixture, and administered to the shrimp body together with the feed; so The composition can be directly added to the culture water, so that the shrimp body can feed freely, thereby improving the convenience of administering the composition.

本發明的組合物的用途,其中,該杏鮑菇萃取物係以每天每公克之蝦體重投予300 μg之劑量投予該蝦體,該植物乳桿菌7-40菌株以每天每公克之蝦體重投予6,000 CFU之劑量投予該蝦體,且連續投予56~60天;如此藉由該組合物的投予劑量而具有較佳的提升蝦體之免疫能力的效果。The use of the composition of the present invention, wherein the King Pleurotus eryngii extract is administered to the shrimp at a dosage of 300 μg per gram of shrimp weight per day, and the Lactobacillus plantarum 7-40 strain is administered to the shrimp at a dosage of 6,000 CFU per gram of shrimp weight per day, and the administration is continued for 56 to 60 days; thus, the administration dosage of the composition has a better effect of enhancing the immune ability of the shrimp.

為讓本發明之上述及其他目的、特徵及優點能更明顯易懂,下文特舉本發明之較佳實施例,並配合所附圖式作詳細說明:In order to make the above and other purposes, features and advantages of the present invention more clearly understood, the following is a preferred embodiment of the present invention, and is described in detail with reference to the accompanying drawings:

本發明所述「蝦類」係可以指養殖蝦,包含但不限於,太平洋白蝦( Litopenaeus vannamei)、草蝦( Penaeus monodon)、斑節蝦( Marsupenaeus japonicus)、中國草蝦( Fenneropenaeus chinensis)、印度對蝦( Fenneropenaeus indicus)、沙蝦( Metapenaeus ensis barbata)、紅尾蝦( Penaeus penicillatus)及淡水長臂大蝦( Macrobrachium rosenbergii)。 The "shrimps" mentioned in the present invention may refer to farmed shrimps, including but not limited to, Pacific white shrimp ( Litopenaeus vannamei ), grass shrimp ( Penaeus monodon ), monodon shrimp ( Marsupenaeus japonicus ), Chinese grass shrimp ( Fenneopenaeus chinensis ), Indian shrimp ( Fenneopenaeus indicus ), sand shrimp ( Metapenaeus ensis barbata ), red tail shrimp ( Penaeus penicillatus ) and freshwater long-armed giant shrimp ( Macrobrachium rosenbergii ).

本發明的用以提升免疫能力的組合物之一實施例係可以包含:一杏鮑菇萃取物及一植物乳桿菌( Lactobacillus plantarum)菌株,以藉由二者的加乘作用(synergestic effect),有效提升蝦類的免疫能力。 One embodiment of the composition for improving immunity of the present invention may include: an extract of Pleurotus eryngii and a strain of Lactobacillus plantarum , so that through the synergestic effect of the two, Effectively improve the immunity of shrimps.

詳而言之,該杏鮑菇萃取物係可以指由水萃取一杏鮑菇( Pleurotus eryngii)樣品所獲得之產物。 Specifically, the Pleurotus eryngii extract may refer to a product obtained by extracting a Pleurotus eryngii sample with water.

較佳地,在以水進行萃取之前,工者可以先將該杏鮑菇樣品可以預先碎成粉粒(粒徑約為0.5~1.0 cm),以增加該杏鮑菇樣品與水之接觸表面積,藉此提升後續萃取之萃取效率。Preferably, before extracting with water, workers can first crush the king oyster mushroom sample into powder (particle size is about 0.5-1.0 cm) to increase the contact surface area between the king oyster mushroom sample and water. , thereby improving the extraction efficiency of subsequent extractions.

舉例而言,工者可以取100公克之杏鮑菇樣品混合200~250毫升之水,於沸騰的狀態下萃取15~20分鐘,上述萃取亦可以重複數次,使該杏鮑菇樣品所含之活性成分可以完整溶於水中,此為本發明所屬技術領域中具有通常知識者所廣泛應用,在此不加以贅述。For example, workers can take 100 grams of King Oyster Mushroom sample and mix it with 200-250 milliliters of water, and extract it for 15-20 minutes under boiling conditions. The above extraction can also be repeated several times so that the active ingredients contained in the King Oyster Mushroom sample can be completely dissolved in water. This is widely used by those with ordinary knowledge in the technical field to which the present invention belongs, and will not be elaborated here.

前述之杏鮑菇萃取液可以再藉由離心(例如於4℃的溫度下,以14,400×g的轉速離心20分鐘)以去除不溶物,在冷卻至室溫之後,即可以將該杏鮑菇萃取液儲存於4℃備用。The aforementioned Pleurotus eryngii extract can be further centrifuged (for example, at 4°C and 14,400×g for 20 minutes) to remove insoluble matter. After cooling to room temperature, the Pleurotus eryngii extract can be stored at 4°C for future use.

值得注意的是,於本實施例中,係選用一杏鮑菇菌托樣品作為該杏鮑菇樣品。一般而言,杏鮑菇等菇蕈類係生長於一基質上,露出的形狀像是一把雨傘,主要包含傘狀的菌蓋(cap)、柱狀的菌柄(stem)及埋藏在該基質中的菌絲(mycelium),該菌蓋的下緣具有皺褶,被稱為菌摺(gill),包含數十萬個孢子(spore)。又,在菌柄及菌絲之間,存在有外徑略大於該菌柄的外徑、且亦露出於該基質之外的菌托(volva)。在採收杏鮑菇時,工者通常不會自該基質將杏鮑菇連同菌絲一同挖出,而僅會取包含該菌柄及該菌蓋的部分,因此該杏鮑菇菌托樣品通常僅被認定為採收杏鮑菇之後剩下的農業廢棄物。It is worth noting that in this embodiment, a Pleurotus eryngii mushroom holder sample is selected as the Pleurotus eryngii sample. Generally speaking, mushrooms such as Pleurotus eryngii grow on a substrate, and the exposed shape is like an umbrella, mainly including an umbrella-shaped cap (cap), a columnar stem (stem), and a mushroom buried in the substrate. The mycelium in the matrix has a wrinkled lower edge called the gill, which contains hundreds of thousands of spores. In addition, between the stipe and the hyphae, there is a volva whose outer diameter is slightly larger than that of the stipe and which is also exposed outside the matrix. When harvesting Pleurotus eryngii, workers usually do not dig out the Pleurotus eryngii together with the mycelium from the substrate, but only take the part containing the stipe and the cap. Therefore, the sample of the Pleurotus eryngii stipe is Usually identified only as the agricultural waste left after harvesting king oyster mushrooms.

又,該植物乳桿菌菌株可以為一植物乳桿菌7-40菌株,該植物乳桿菌7-40菌株業已於2022年05月12日寄存於中華民國食品工業發展研究所(寄存編號為BCRC 911128)。需要說明的是,該植物乳桿菌7-40菌株的菌學特徵業已公開於 邱秋霞Lactobacillus plantarumNTU102生理特性及其在保健食品與水產養殖應用之探討」博士論文(其中所載之 Lactobacillus plantarumNTU102即為該植物乳桿菌7-40菌株),於此不再贅述。 In addition, the Lactobacillus plantarum strain can be a Lactobacillus plantarum 7-40 strain. The Lactobacillus plantarum 7-40 strain has been deposited at the Food Industry Development Institute of the Republic of China on May 12, 2022 (deposit number is BCRC 911128) . It should be noted that the mycological characteristics of the Lactobacillus plantarum 7-40 strain have been disclosed in Qiu Qiuxia's doctoral thesis "Discussion on the Physiological Characteristics of Lactobacillus plantarum NTU102 and its Application in Health Food and Aquaculture" ( the Lactobacillus plantarum NTU102 contained in it is This is the Lactobacillus plantarum 7-40 strain), which will not be described again here.

該組合物係可以供投予一蝦體,例如能夠以經口餵食的方式投予該蝦體,使該蝦體可以自由攝食該杏鮑菇萃取物及該植物乳桿菌7-40菌株,進而使該杏鮑菇萃取物及該植物乳桿菌7-40菌株能夠共同作用以提升該蝦體的免疫能力﹝例如,提升血球細胞的溶菌酶(lysozyme)活性﹞,因此當該蝦體受到溶藻弧菌等病原菌的感染時,可以降低該蝦體遭受病原菌攻擊所造成之死亡。The composition can be administered to a shrimp, for example, by oral feeding, so that the shrimp can freely ingest the King Pleurotus eryngii extract and the Lactobacillus plantarum 7-40 strain, thereby allowing the King Pleurotus eryngii extract and the Lactobacillus plantarum 7-40 strain to work together to enhance the shrimp's immune ability (for example, enhance the lysozyme activity of blood cells), so that when the shrimp is infected by pathogens such as Vibrio alginolyticus, the shrimp can be less likely to die from the attack of pathogens.

舉例而言,工者可以將該組合物添加於一飼料中,以與該飼料共同形成一混合物(例如使每公斤的混合物中包含5~6公克的杏鮑菇萃取物及10 8CFU的植物乳桿菌7-40菌株)。接著,工者可以選用重量約為0.35~0.37公克之蝦體,並連續將該混合物投於養殖水中56~60天,供該蝦體可以自由攝食,使該杏鮑菇萃取物係以每天每公克之蝦體重投予300 μg之劑量投予該蝦體,且該植物乳桿菌7-40菌株以每天每公克之蝦體重投予6,000 CFU之劑量投予該蝦體。 For example, workers can add the composition to a feed to form a mixture with the feed (for example, each kilogram of the mixture includes 5 to 6 grams of Pleurotus eryngii extract and 10 8 CFU of plant Lactobacillus strain 7-40). Then, workers can select shrimp bodies weighing about 0.35 to 0.37 grams, and continuously put the mixture into the culture water for 56 to 60 days, so that the shrimp bodies can eat freely, so that the Pleurotus eryngii extract can be consumed every day. A dose of 300 μg per gram of shrimp body weight was administered to the shrimp body, and the Lactobacillus plantarum 7-40 strain was administered to the shrimp body at a dose of 6,000 CFU per gram of shrimp body weight per day.

舉例而言,工者可以選用如第1表所示的飼料的配方,且在加入該組合物時,係分別以該杏鮑菇萃取物及該植物乳桿菌7-40菌株取代等量的脫脂奶粉及纖維素。For example, a worker may select the feed formula shown in Table 1, and when adding the composition, replace the same amount of skimmed milk powder and cellulose with the King Oyster Mushroom extract and the Lactobacillus plantarum 7-40 strain, respectively.

第1表、飼料的配方(1公斤) 成分 含量(公克) 魚粉(fish meal) 405 豆粉(soybean meal) 300 烏賊粉(squid meal) 50 α澱粉(α-starch) 150 維他命混合粉 1 20 礦物質混合粉 2 40 魚油(fish oil) 29 脫脂奶粉(slim milk) 1 纖維素(cellulose) 5 1:每公克的維他命混合粉包含5.15毫克的泛酸(calcium pantothenate)、0.0037毫克的維生素D3(cholecalciferol)、153.8毫克的膽鹼(choline chloride)、0.0074毫克的維生素B12(cyanocobalamine)、10毫克的維生素E( DL-α-tocopheryl acetate)、0.09毫克的生物素(d-biotin)、0.08毫克的葉酸(folic acid)、100毫克的肌醇(inositol)、1.5毫克的維生素K3(menadione)、0.27毫克的菸鹼酸(nicotinic acid)、10毫克的對氨基苯甲酸(para-aminobenzoic acid)、1.5毫克的維生素B6(pyridoxine hydrochloride)、0.64毫克的維生素A(retinol acetate)、0.83毫克的核黃素(riboflavin)及0.52毫克的維生素B1(thiamine hydrochloride),並以α-纖維素(α-cellulose)補至1公克。 2:每公克的礦物質混合粉包含200毫克的磷酸氫二鉀(potassium hydrogen phosphate,K 2HPO 4)、215毫克的磷酸二氫鈉(sodium dihydrogen phosphate,NaH 2PO 4)、265毫克的磷酸二氫鈣(calcium dihydrogen phosphate,Ca(H 2PO 4).H 2O)、105毫克的碳酸鈣(calcium carbonate,CaCO 3)、28毫克的氯化鉀(potassium chloride,KCl)、0.233毫克的碘化鉀(potassium iodide,KI)、100毫克的硫酸鎂(magnesium sulfate,MgSO 4.7H 2O)、0.153毫克的氯化銅(copper chloride,CuCl 2.2H 2O)、0.240毫克的氯化鋁(aluminum chloride,AlCl 3.6H 2O)及0.240毫克的硫酸鋅(zinc sulfate,ZnSO 4.7H 2O),並以α-纖維素補至1公克。 Table 1, feed formula (1kg) Element Content (gram) fish meal 405 soybean meal 300 Squid meal 50 α-starch 150 Vitamin Mix Powder 1 20 Mineral Mix Powder 2 40 fish oil 29 skimmed milk powder (slim milk) 1 Cellulose 5 1 : Each gram of vitamin mixed powder contains 5.15 mg of pantothenic acid (calcium pantothenate), 0.0037 mg of vitamin D3 (cholecalciferol), 153.8 mg of choline (choline chloride), 0.0074 mg of vitamin B12 (cyanocobalamine), and 10 mg of vitamin B12 (cyanocobalamine). E ( DL -α-tocopheryl acetate), 0.09 mg of biotin (d-biotin), 0.08 mg of folic acid, 100 mg of inositol, 1.5 mg of vitamin K3 (menadione), 0.27 mg of nicotinic acid, 10 mg of para-aminobenzoic acid, 1.5 mg of vitamin B6 (pyridoxine hydrochloride), 0.64 mg of vitamin A (retinol acetate), 0.83 mg of riboflavin ( riboflavin) and 0.52 mg of vitamin B1 (thiamine hydrochloride), supplemented to 1 gram with α-cellulose. 2 : Each gram of mineral mixed powder contains 200 mg of potassium hydrogen phosphate (K 2 HPO 4 ), 215 mg of sodium dihydrogen phosphate (NaH 2 PO 4 ), and 265 mg of phosphoric acid Calcium dihydrogen phosphate (Ca(H 2 PO 4 ).H 2 O), 105 mg of calcium carbonate (CaCO 3 ), 28 mg of potassium chloride (KCl), 0.233 mg of Potassium iodide (KI), 100 mg of magnesium sulfate (MgSO 4 .7H 2 O), 0.153 mg of copper chloride (CuCl 2 .2H 2 O), 0.240 mg of aluminum chloride ( aluminum chloride, AlCl 3 .6H 2 O) and 0.240 mg of zinc sulfate (zinc sulfate, ZnSO 4 .7H 2 O), and supplemented with α-cellulose to 1 gram.

為證實本發明之組合物確實具有提升蝦體免疫能力的活性,遂進行以下試驗:In order to confirm that the composition of the present invention indeed has the activity of improving the immunity of shrimps, the following tests were carried out:

(A)杏鮑菇萃取物的製備(A) Preparation of King Oyster Mushroom Extract

本試驗係取500公克的杏鮑菇菌托樣品,混合1,000毫升的去離子水,倒入2,000毫升的玻璃燒杯中,並以鋁箔覆蓋住該玻璃燒杯的開口,接著煮沸15分鐘。在冷卻至室溫之後,將該混合物於4℃的溫度下進行離心(14,400×g)20分鐘,收取上清液之後,再次煮沸15分鐘,並且冷卻至室溫後,儲存於4℃的溫度下備用,如此即可以獲得體積約為1000毫升、重量約為500公克的杏鮑菇萃取液,經乾燥去除水分之後可以獲得約為5公克的杏鮑菇萃取物。In this test, 500 grams of Pleurotus eryngii mushroom base sample was mixed with 1,000 ml of deionized water, poured into a 2,000 ml glass beaker, the opening of the glass beaker was covered with aluminum foil, and then boiled for 15 minutes. After cooling to room temperature, the mixture was centrifuged (14,400 × g) at 4°C for 20 minutes. The supernatant was collected, boiled again for 15 minutes, cooled to room temperature, and stored at 4°C. In this way, a Pleurotus eryngii extract with a volume of about 1000 ml and a weight of about 500 grams can be obtained. After drying and removing the water, about 5 grams of Pleurotus eryngii extract can be obtained.

(B)杏鮑菇萃取物對植物乳桿菌7-40菌株的生長促進效果(B) Growth-promoting effect of Pleurotus eryngii extract on Lactobacillus plantarum 7-40 strain

本試驗係選用如第2表所示的細菌,將200 μL的細菌母液(約含2×10 8CFU的微生物)轉移至20毫升的杏鮑菇萃取物中,將該植物乳桿菌7-40菌株培養於37℃的溫度下24小時;溶藻弧菌、副溶血弧菌及哈維氏弧菌則培養於27℃的溫度下24小時,並且於培養的第6、12、24小時的時間點計算各細菌的濃度。 This test uses the bacteria shown in Table 2. 200 μL of bacterial stock solution (containing approximately 2×10 8 CFU of microorganisms) is transferred to 20 ml of Pleurotus eryngii extract. The Lactobacillus plantarum 7-40 The strains were cultured at 37°C for 24 hours; Vibrio alginolyticus, Vibrio parahaemolyticus and Vibrio harveyi were cultured at 27°C for 24 hours, and at the 6th, 12th and 24th hours of culture Calculate the concentration of each bacteria.

第2表、本試驗各組的細菌 組別 細菌 B1 植物乳桿菌7-40菌株 B2 溶藻弧菌( Vibro alginolyticus B3 副溶血弧菌( Vibro parahaemolyticus B4 哈維氏弧菌( Vibro harveyi Table 2. Bacteria in each group of this experiment Group germ B1 Lactobacillus plantarum strain 7-40 B2 Vibro alginolyticus B3 Vibro parahaemolyticus B4 Vibrio harveyi

請參照第1圖所示,僅有第B1組的植物乳桿菌7-40菌株在以該杏鮑菇萃取物進行培養時能夠持續生長,且於第24小時的時間點時,與第B2組的溶藻弧菌、第B3組的副溶血弧菌及第B4組的哈維氏弧菌的細菌濃度均具有顯著差異( P<0.05)。 As shown in Figure 1, only the Lactobacillus plantarum 7-40 strain in Group B1 was able to continue growing when cultured with the Pleurotus eryngii extract, and at the 24th hour point, the bacterial concentrations of the strains were significantly different from those of the Vibrio alginolyticus in Group B2, the Vibrio parahaemolyticus in Group B3, and the Vibrio harveyi in Group B4 ( P < 0.05).

又,選用從國立屏東科技大學水產養殖系教學實習場取得的太平洋白蝦(平均體重為0.35~0.37公克),先將該太平洋白蝦置於實驗室養殖一週,使該太平洋白蝦適應試驗養殖環境(海水環境,鹽度為25 ppt;水溫為28±1℃;pH值為8±0.05),並於禁食一天之後,進行後續試驗:In addition, Pacific white shrimp (average weight 0.35-0.37 g) obtained from the teaching and practice field of the Department of Aquaculture of National Pingtung University of Science and Technology were selected and cultured in the laboratory for one week to adapt to the experimental culture environment (seawater environment, salinity 25 ppt; water temperature 28±1℃; pH value 8±0.05). After fasting for one day, subsequent experiments were carried out:

(C)對免疫因子的影響(C)Effects on immune factors

請參照第3表所示,本試驗係以該植物乳桿菌7-40菌株取代該飼料中的脫脂奶粉,以作為用以餵食第C2組太平洋白蝦的混合物;以該杏鮑菇萃取物取代該飼料中的纖維素,以作為用以餵食第C3組太平洋白蝦的混合物;以該植物乳桿菌7-40菌株、該杏鮑菇萃取物分別取代該飼料中的脫脂奶粉、纖維素,以作為用以餵食第C4組太平洋白蝦的混合物;另以第1表所示的飼料做為用以餵食第C1組太平洋白蝦的混合物,將前述混合物投於養殖水中,供該太平洋白蝦可以自由攝食,並且連續使該太平洋白蝦自由攝食前述混合物56~60天。As shown in Table 3, in this test, the skimmed milk powder in the feed was replaced by the plant lactobacillus 7-40 strain to form a mixture for feeding Pacific white shrimps in Group C2; the cellulose in the feed was replaced by the King Pleurotus ostreatus extract to form a mixture for feeding Pacific white shrimps in Group C3; the skimmed milk powder and cellulose in the feed were replaced by the plant lactobacillus 7-40 strain and the King Pleurotus ostreatus extract respectively to form a mixture for feeding Pacific white shrimps in Group C4; and the feed shown in Table 1 was used as a mixture for feeding Pacific white shrimps in Group C1. The above mixture was added to the culture water for free intake by the Pacific white shrimps, and the Pacific white shrimps were allowed to freely intake the above mixture for 56 to 60 consecutive days.

第3表、本試驗各組之混合物中的添加物 組別 添加物 C1 C2 植物乳桿菌7-40菌株(10 8CFU) 1 C3 杏鮑菇萃取物(5公克) 2 C4 植物乳桿菌7-40菌株(10 8CFU) 1、 杏鮑菇萃取物(5公克) 2 1:以蝦體的平均體重為0.35~0.37公克、每隻蝦體每天攝食的混合物的量為0.021~0.022公克進行計算,投予劑量約為6,000 CFU/g 蝦體; 2:以蝦體的平均體重為0.35~0.37公克、每隻蝦體每天攝食的混合物的量為0.021~0.022公克進行計算,投予劑量約為300 μg/g蝦體。 Table 3: Additives in the mixtures of each group of this test Group Additives C1 without C2 Lactobacillus plantarum strain 7-40 (10 8 CFU) 1 C3 King Oyster Mushroom Extract (5g) 2 C4 Lactobacillus plantarum strain 7-40 (10 8 CFU) 1. Pleurotus eryngii extract (5 grams) 2 1 : Calculated based on the average body weight of shrimp being 0.35 to 0.37 grams and the amount of mixture consumed by each shrimp per day being 0.021 to 0.022 grams, the dosage is approximately 6,000 CFU/g shrimp; 2 : Based on the amount of shrimp. The average body weight is 0.35-0.37 grams, and the amount of the mixture consumed by each shrimp per day is 0.021-0.022 grams. The dosage is approximately 300 μg/g shrimp.

接著,自頭胸甲腹面的血竇處抽取血淋巴(hemolymph),將血淋巴以1:9之體積比加入﹝內含30 mM的檸檬酸鈉(trisodium citrate)、0.34 M的氯化鈉(NaCl,sodium chloride)及10 mM的乙二胺四乙胺(ethylenediaminetetraacetic acid,EDTA),以鹽酸(HCl)水溶液及/或氫氧化鈉(NaOH)水溶液將pH調整為7.5,並以氯化鈉將滲透壓調整為780 mOsm/kg﹞,混合均勻以獲得包含抗凝劑的血淋巴混合液。Next, hemolymph was extracted from the blood sinus on the ventral surface of the cephalothorax, and the hemolymph was added at a volume ratio of 1:9 (containing 30 mM sodium citrate (trisodium citrate), 0.34 M sodium chloride ( NaCl, sodium chloride) and 10 mM ethylenediaminetetraacetic acid (EDTA), adjust the pH to 7.5 with hydrochloric acid (HCl) aqueous solution and/or sodium hydroxide (NaOH) aqueous solution, and use sodium chloride to The osmotic pressure is adjusted to 780 mOsm/kg﹞, and the hemolymph mixture containing anticoagulant is obtained by mixing evenly.

將該血淋巴混合液離心去除上清液之後,加入1 mL、0.1 M的磷酸鹽緩衝生理鹽水﹝sodium phosphate buffer,PBS buffer;內含22.5 mM的磷酸一氫鈉(sodium hydrogen phosphate,Na 2HPO 4)及77.5 mM的磷酸二氫鈉(sodium dihydrogen phosphate,NaH 2PO 4),以磷酸一氫鈉水溶液及/或磷酸二氫鈉水溶液將pH值調整為6.2﹞進行清洗,去除上清液之後再回溶於50 μL的磷酸鹽緩衝生理鹽水,在以超音波破碎儀進行破碎之後,即可以取得血球細胞均質液。 After the hemolymph mixture is centrifuged and the supernatant is removed, 1 mL of 0.1 M phosphate buffered saline (sodium phosphate buffer, PBS buffer; containing 22.5 mM sodium hydrogen phosphate (Na 2 HPO 4 ) and 77.5 mM sodium dihydrogen phosphate (NaH 2 PO 4 ), the pH value is adjusted to 6.2 with sodium hydrogen phosphate aqueous solution and/or sodium dihydrogen phosphate aqueous solution) is added for washing. After removing the supernatant, it is re-dissolved in 50 μL of phosphate buffered saline and disrupted with an ultrasonic disruptor to obtain a blood cell homogenate.

取10 μL的血球細胞均質液置於96孔盤中,並與200 μL的藤黃微球菌( Micrococcus luteus)菌液混合,偵測於反應第30秒及第5分鐘的時間點下,於530 nm波長下的吸光值,以換算溶菌酶的活性。結果如第2圖所示,投予本發明之組合物的第C4組太平洋白蝦的溶菌酶活性有顯著提升,且效果顯著優於僅投予該植物乳桿菌7-40菌株的第C2組太平洋白蝦及僅投予該杏鮑菇萃取物的第C3組太平洋白蝦( P<0.05)。 Take 10 μL of blood cell homogenate and place it in a 96-well plate, mix it with 200 μL of Micrococcus luteus bacterial solution, and detect at the time points of 30 seconds and 5 minutes of reaction, at 530 The absorbance value at nm wavelength is used to convert the activity of lysozyme. The results are shown in Figure 2. The lysozyme activity of group C4 of Pacific white shrimps administered the composition of the present invention was significantly improved, and the effect was significantly better than that of group C2 of group C4 only administered the Lactobacillus plantarum 7-40 strain. Pacific white shrimp and Group C3 Pacific white shrimp that were only administered the Pleurotus eryngii extract ( P <0.05).

(D)溶藻弧菌感染之後的存活率(D)Survival rate after infection with Vibrio alginolyticus

接著,再請參照第4表所示,本試驗同樣將前述混合物投於養殖水中,供該太平洋白蝦可以自由攝食,並且於連續使該太平洋白蝦自由攝食前述混合物56天之後,分別以溶藻弧菌注射各組太平洋白蝦,使該太平洋白蝦感染溶藻弧菌(感染劑量為1.5×10 5CFU/公克蝦體),並於0、24、48、72及96小時分別計算各組太平洋白蝦的死亡率。 Next, please refer to Table 4. In this experiment, the aforementioned mixture was also put into the culture water so that the Pacific white shrimp could freely eat. After continuously allowing the Pacific white shrimp to freely eat the aforementioned mixture for 56 days, the mixture was dissolved in solution. Each group of Pacific white shrimps was injected with Vibrio alginolyticus to infect the Pacific white shrimps with Vibrio alginolyticus (infectious dose was 1.5×10 5 CFU/g shrimp body), and each group was calculated at 0, 24, 48, 72 and 96 hours. Mortality of group Pacific white shrimp.

第4表、本試驗各組之混合物中的添加物 組別 添加物 D1 D2 植物乳桿菌7-40菌株(10 8CFU) 1 D3 杏鮑菇萃取物(5公克) 2 D4 植物乳桿菌7-40菌株(10 8CFU) 1、 杏鮑菇萃取物(5公克) 2 1:以蝦體的平均體重為0.35~0.37公克、每隻蝦體每天攝食的混合物的量為0.021~0.022公克進行計算,投予劑量約為6,000 CFU/g蝦體; 2:以蝦體的平均體重為0.35~0.37公克、每隻蝦體每天攝食的混合物的量為0.021~0.022公克進行計算,投予劑量約為300 μg/g蝦體。 Table 4: Additives in the mixtures of each group of this test Group Additives D1 without D2 Lactobacillus plantarum strain 7-40 (10 8 CFU) 1 D3 King Oyster Mushroom Extract (5g) 2 D4 Lactobacillus plantarum strain 7-40 (10 8 CFU) 1. Pleurotus eryngii extract (5 grams) 2 1 : Calculated based on the average body weight of shrimp being 0.35 to 0.37 grams and the amount of mixture consumed by each shrimp per day being 0.021 to 0.022 grams, the dosage is approximately 6,000 CFU/g shrimp; 2 : Based on the shrimp body weight The average body weight is 0.35 to 0.37 grams, and the amount of the mixture consumed by each shrimp body per day is 0.021 to 0.022 grams. The dosage is approximately 300 μg/g shrimp body.

請參照第3圖所示,投予本發明之組合物的第D4組太平洋白蝦於第24~96小時內的死亡率均有顯著地降低,其中於第96小時的時間點的存活率仍可以達約95%,顯示本發明之組合物可以有效預防溶藻弧菌的感染,降低太平洋白蝦受到溶藻弧菌的感染而死亡的風險。As shown in Figure 3, the mortality rate of Pacific white shrimp in Group D4 administered with the composition of the present invention was significantly reduced within 24 to 96 hours, and the survival rate at the 96th hour time point was still the same. It can reach about 95%, indicating that the composition of the present invention can effectively prevent infection by Vibrio alginolyticus and reduce the risk of death of Pacific white shrimp due to infection by Vibrio alginolyticus.

綜上所述,本發明的組合物包含該杏鮑菇萃取物及該植物乳桿菌7-40菌株,因此可以藉由二者的加乘作用,達成有效提升蝦類的免疫能力之功效。In summary, the composition of the present invention comprises the Pleurotus eryngii extract and the Lactobacillus plantarum 7-40 strain, and thus can achieve the effect of effectively enhancing the immunity of shrimps through the synergistic effect of the two.

再且,本發明的組合物的用途,係藉由該杏鮑菇萃取物及該植物乳桿菌7-40菌株的共同使用,可以促進蝦類的細胞免疫反應(例如提升血球細胞溶菌酶活性),因此當受到溶藻弧菌等病原菌的感染時,可以降低蝦類遭受病原菌攻擊所造成之死亡,是以可以降低養殖業者於養殖過程中的抗生素使用量,為本發明之功效。Furthermore, the use of the composition of the present invention is to promote the cellular immune response of shrimp (such as increasing the lysozyme activity of blood cells) through the joint use of the Pleurotus eryngii extract and the Lactobacillus plantarum 7-40 strain. , therefore when infected by pathogenic bacteria such as Vibrio alginolyticus, it can reduce the death of shrimps caused by pathogenic bacteria attack, so it can reduce the amount of antibiotics used by farmers in the breeding process, which is the effect of the present invention.

此外,本發明的組合物的用途,係以該杏鮑菇菌托樣品作為原料,使原本被認定為農業廢棄物的菌托具有新的經濟價值,達成為菌托創造新的經濟出路之功效。In addition, the use of the composition of the present invention is to use the Pleurotus eryngii mushroom tray sample as a raw material to give the mushroom tray that was originally recognized as agricultural waste a new economic value and achieve the effect of creating a new economic outlet for the mushroom tray. .

雖然本發明已利用上述較佳實施例揭示,然其並非用以限定本發明,任何熟習此技藝者在不脫離本發明之精神和範圍之內,相對上述實施例進行各種更動與修改仍屬本發明所保護之技術範疇,因此本發明之保護範圍當包含後附之申請專利範圍所記載的文義及均等範圍內之所有變更。Although the present invention has been disclosed using the above-mentioned preferred embodiments, they are not intended to limit the present invention. Any person skilled in the art may make various changes and modifications to the above-mentioned embodiments without departing from the spirit and scope of the present invention, and the scope of protection of the present invention shall include all changes within the meaning and equivalent scope recorded in the attached patent application.

without

[第1圖] 試驗(B)中,第B1~B4組微生物的濃度變化圖。 [第2圖] 試驗(C)中,第C1~C4組太平洋白蝦之血球細胞的溶菌酶活性。 [第3圖] 試驗(D)中,第D1~D4組太平洋白蝦於96小時內的累積死亡率。 [Picture 1] Concentration changes of microorganisms in groups B1 to B4 in test (B). [Picture 2] In test (C), lysozyme activity of hemocytes of Pacific white shrimp in groups C1 to C4. [Picture 3] In experiment (D), the cumulative mortality rate of Pacific white shrimp in groups D1 to D4 within 96 hours.

國內寄存資訊 植物乳桿菌7-40:中華民國食品工業發展研究所、2022年05月12日、BCRC 911128。 Domestic storage information Lactobacillus plantarum 7-40: Institute of Food Industry Development of the Republic of China, May 12, 2022, BCRC 911128.

Claims (7)

一種用以提升免疫能力的組合物,包含: 一杏鮑菇萃取物,該杏鮑菇萃取物係以水於沸騰的狀態下萃取一杏鮑菇樣品獲得;及 一植物乳桿菌7-40菌株,該植物乳桿菌7-40菌株係寄存於中華民國食品工業發展研究所,該植物乳桿菌7-40菌株的寄存編號為BCRC 911128。 A composition for enhancing immunity, comprising: A Pleurotus eryngii extract, which is obtained by extracting a Pleurotus eryngii sample with boiling water; and A Lactobacillus plantarum 7-40 strain, which is deposited in the Food Industry Development Institute of the Republic of China, and the deposit number of the Lactobacillus plantarum 7-40 strain is BCRC 911128. 如請求項1之用以提升免疫能力的組合物,其中,每公斤的組合物包含5~6公克的杏鮑菇萃取物及10 8CFU的植物乳桿菌7-40菌株。 The composition for enhancing immunity as claimed in claim 1, wherein each kilogram of the composition comprises 5-6 grams of Pleurotus eryngii extract and 10 8 CFU of Lactobacillus plantarum 7-40 strain. 如請求項1或2之用以提升免疫能力的組合物,其中,該杏鮑菇樣品係一杏鮑菇菌托樣品。The composition for improving immunity according to claim 1 or 2, wherein the Pleurotus eryngii sample is a Pleurotus eryngii mushroom pedicle sample. 一種如請求項1~3中任一項之組合物的用途,係用以製備提升蝦體免疫能力之藥物,該組合物係投予一蝦體,以增強該蝦體之免疫能力。The use of a composition according to any one of claims 1 to 3 is to prepare a drug for improving the immunity of shrimp. The composition is administered to a shrimp to enhance the immunity of the shrimp. 如請求項1之組合物的用途,其中,該組合物係以經口餵食的方式投予該蝦體。The use of the composition of claim 1, wherein the composition is administered to the shrimp body in an oral feeding manner. 如請求項5之組合物的用途,其中,該組合物係與一飼料混合形成一混合物,並與該飼料共同投予該蝦體。The use of the composition of claim 5, wherein the composition is mixed with a feed to form a mixture, and is administered to the shrimp body together with the feed. 如請求項5或6之組合物的用途,其中,該杏鮑菇萃取物係以每天每公克之蝦體重投予 300 μg之劑量投予該蝦體,該植物乳桿菌7-40菌株以每天每公克之蝦體重投予6,000 CFU之劑量投予該蝦體,且連續投予56~60天。For example, claim the use of the composition of item 5 or 6, wherein the Pleurotus eryngii extract is administered to the shrimp at a dose of 300 μg per gram of shrimp body weight per day, and the Lactobacillus plantarum 7-40 strain is administered to the shrimp at a dose of 300 μg per gram of shrimp body weight per day. A dose of 6,000 CFU per gram of shrimp body weight was administered to the shrimp body for 56 to 60 days.
TW111130782A 2022-08-16 2022-08-16 Composition for boosting immunity and use thereof TWI820864B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW111130782A TWI820864B (en) 2022-08-16 2022-08-16 Composition for boosting immunity and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW111130782A TWI820864B (en) 2022-08-16 2022-08-16 Composition for boosting immunity and use thereof

Publications (2)

Publication Number Publication Date
TWI820864B TWI820864B (en) 2023-11-01
TW202408557A true TW202408557A (en) 2024-03-01

Family

ID=89722275

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111130782A TWI820864B (en) 2022-08-16 2022-08-16 Composition for boosting immunity and use thereof

Country Status (1)

Country Link
TW (1) TWI820864B (en)

Also Published As

Publication number Publication date
TWI820864B (en) 2023-11-01

Similar Documents

Publication Publication Date Title
Macey et al. Improved growth rate and disease resistance in farmed Haliotis midae through probiotic treatment
Sarlin et al. Efficacy of marine yeasts and baker's yeast as immunostimulants in Fenneropenaeus indicus: a comparative study
Zhao et al. Effects of dietary supplementation of probiotics on growth, immune responses, and gut microbiome of the abalone Haliotis diversicolor
Wang et al. Enhancement of non-specific immune response in sea cucumber (Apostichopus japonicus) by Astragalus membranaceus and its polysaccharides
Luis-Villaseñor et al. Beneficial effects of four Bacillus strains on the larval cultivation of Litopenaeus vannamei
Chandrakala et al. Vibriosis in shrimp aquaculture a review
CN103385381B (en) Special compound feed for litopenaeus vannamei
Partida-Arangure et al. Effect of inulin and probiotic bacteria on growth, survival, immune response, and prevalence of white spot syndrome virus (WSSV) in Litopenaeus vannamei cultured under laboratory conditions
CN108289479A (en) Composition for aquaculture and/or combination
Van Doan et al. Administration of watermelon rind powder to Nile tilapia (Oreochromis niloticus) culture under biofloc system: Effect on growth performance, innate immune response, and disease resistance
KR101663570B1 (en) Feed additive containing Pyeong wee-San sludge extract and functional feed using thereof
Harikrishnan et al. Effect of Agaricus bisporus enriched diet on growth, hematology, and immune protection in Clarias gariepinus against Flavobacterium columnare
Sahoo et al. Nutritional and biological control synergism against gastrointestinal nematodes in small ruminants
CN107821739A (en) The application of composite feed additive, the preparation method of antivirotic and antivirotic
CN113403222B (en) Lactobacillus acidophilus, aquatic feed additive, fish feed and application of lactobacillus acidophilus and aquatic feed additive
CN103315151A (en) Special feed additive for South American white shrimp
Chotikachinda et al. Effect of inactive yeast cell wall on growth performance, survival rate and immune parameters in Pacific White Shrimp (Litopenaeus vannamei).
TWI820864B (en) Composition for boosting immunity and use thereof
CN111676197A (en) Vibrio harveyi phage, phage composition and application thereof
CN105104715A (en) Feed preventing vibrio infection of xenocypris davidi and preparation method thereof
CN105380939A (en) Genistein and application of medicinal derivative thereof in preparation of medicine for resisting eimeria tenella
KR20170001379A (en) Inactivated vaccine composition against atypical Aeromonas salmonicida in rockfish
Jueliang et al. The effects of probiotic, β-1, 3-glucan and organic acid on Pacific white shrimp’s (Litopenaeus vannamei) immune system and survival upon challenge with Vibrio harveyi
Khatun et al. Effect of different probiotics on growth, survival and production of monosex Nile tilapia (Oreochromis niloticus)
TWI832304B (en) Use of extract of mangosteen husk